Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Chokri Ben Lamine: High-Yield Pearls from a Heme Perspective on Uremic Coagulopathy
May 2, 2026, 15:15

Chokri Ben Lamine: High-Yield Pearls from a Heme Perspective on Uremic Coagulopathy

Chokri Ben Lamine,  Assistant consultant at King Faisal Specialist Hospital and Research Center, shared a post on X:

Uremic Coagulopathy — High-Yield Pearls (Heme Perspective)

  • Pathophysiology is platelet dysfunction (not factor deficiency)
  • Mechanism is impaired platelet adhesion with aggregation
  • Key toxins include guanidinosuccinic acid, phenols, PTH
  • Decreased vWF interaction leads to defective GP Ib–vWF binding
  • Platelet count is usually normal
  • PT/PTT is usually normal
  • Bleeding time and PFA-100 is prolonged

Clinical picture

  • Mucocutaneous bleeding (epistaxis, gingival)
  • Easy bruising, petechiae
  • GI bleeding common
  • Increased Post-procedure bleeding risk

Triggers worsening bleeding

  • Uremia (BUN 60–80 mg/dL)
  • Anemia ( Decreased Hct worsens platelet function)
  • Concomitant antiplatelets NSAIDs
  • Dialysis delay

Diagnosis (clinical)

  • CKD/ESRD context
  • Normal coagulation profile
  • Platelet dysfunction pattern
  • Exclusion of DIC/liver disease

Management (stepwise — guideline-based)

1.Dialysis is definitive

  • Rapid improvement within 24–48h
  • First-line in active bleeding

2.DDAVP (Desmopressin)

  • 0.3 mcg/kg IV over 20–30 min
  • Onset – 1–2 h
  • Duration – 6–8 h
  • Tachyphylaxis after 1–2 doses

3.Correct anemia

  • Target Hb 10 g/dL
  • RBC transfusion improves platelet interaction

4.Cryoprecipitate

  • If bleeding persists
  • Works via vWF fibrinogen
  • Effect within hours

5.Conjugated estrogens

  • 0.6 mg/kg IV daily 5 days
  • Delayed onset (6–24 h)
  • Longer effect (1–2 weeks)

Avoid

  • Platelet transfusion (limited role unless thrombocytopenia)
  • NSAIDs aspirin

Practical procedural prep

  • Dialyze pre-procedure
  • Give DDAVP 30–60 min before
  • Ensure Hb optimized
  • Consider cryo if high-risk

Evidence pearls

  • DDAVP is transient but effective (standard of care for urgent bleeding)
  • Dialysis is cornerstone (KDIGO CKD guidelines)
  • Estrogens are useful in recurrent bleeding when dialysis insufficient

MCQ

Patient with ESRD and epistaxis and normal PT and PTT:

What is the best immediate therapy?

  1. FFP
  2. Platelets
  3. DDAVP
  4. Vitamin K

Answer:

C (DDAVP) — fastest hemostatic correction

OSCE scenario

ESRD patient needs central line

Plan:

Perform dialysis, then administer DDAVP pre-procedure, optimize hemoglobin, and avoid NSAIDs”

Other posts featuring Chokri Ben Lamine on Hemostasis Today.